Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

29 October 2020
Pharma

Visiongain has published a new report on Clinical Trial Supplies Market Report : Forecasts by Products & Services (Manufacturing, Packaging, Logistics, Distribution and Storage), Phases (l, ll, lll, lV), Drug Type (Small Molecule, Biologics), Therapeutic Areas (Oncology, Blood Disorders. PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Depending on the products and service, the market is bifurcated into Manufacturing, Packaging, Logistics, Distribution, and Storage. The logistic service sector is expected to be on top on the market due to the globalisation of clinical trials and increase in number of clinical trials including temperature sensitive products. And the comparator sourcing service segment is expected to grow at the highest CAGR during the forecast period.

North America is the largest regional market for clinical trial supplies, and this trend is anticipated to continue during the forecast period of 2020 to 2025. The presence of well-established CROs (Contract research organization) and the high and growing investments in R&D by pharmaceutical and biopharmaceutical companies are the major factors responsible for the large share of North America in the global clinical trial supplies market. Conversely, owing to the existence of a larger patient population and less-strict patient staffing regulations, the Asia Pacific market is expected to grow at the highest CAGR during the analysis period.

COVID-19 Impact on Clinical trial supplies Market
By the impact of COVID19 the clinical trial supply industry have a challenge to keep their trials in continuation. It is very important to distribute drug product among different regions and receive biological trials and transfer those samples to central labs, because of this pandemic the market is moving again in decentralised model of conducting clinical trials for result in high recovery rate of covid19 patients. Due to restriction on logistic industry it is very important to understand to manage clinical trials.

Market Drivers
Clinical phase insights- phase 1 is expected to grow faster due to increase in number of outsourced phase 1 trials. Outsourcing is increasing because of lesser population sample and higher capital investment.

End use insights- biologics is expected to grow faster based on end use while pharmaceutical is expected to grow faster in forecast period.

Market Opportunities
Opportunity 1- due to the presence of well-established CROs and growing investment in R&D by pharmaceutical and biopharmaceutical companies the demand in clinical trials is increased.

Opportunity 2- due to COVID19 pandemic the pharma companies is outsourcing the trails for better medicine and in search for launching the vaccines.

Competitive Landscape
- CROs are witnessing strong growth in the global clinical trial material and supplies market
- Clinical trial materials and supplies market is becoming more and more fragmented and expected to experience huge changes in terms of competition
- Recent partnership acquisition and expansion have taken place in the global clinical trial market and supplies market.
- Major players in the market include: Alamc Group (UK), Catalent, Inc. (US), PCI Services (US), Parexel International Corporation (US), Sharp Packaging Services (US), Biocair (UK), O&M Movianto (US), KLIFO A/S (Denmark), Thermo Fisher Scientific, Inc. (US), Capsugel (Switzerland), UDG Healthcare Plc. (Ireland), Bilcare Limited (India), Infosys (India), PRA Health Sciences, Inc. (US), Eurofins Scientific (Luxembourg), Marken (US), Seveillar Clinical Trial Supplies Pvt. Ltd. (India), and N-SIDE (Belgium).

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

Read

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

Read

Visiongain Publishes Biological Imaging Reagents Market Report 2021-2031

Increasing prevalence of cardiovascular diseases is increasing demand of biological imaging reagents for the diagnosis and treatment of cardiovascular diseases due to this reason increasing prevalence of cardiovascular diseases is acting as a driver for biological imaging reagent market.

13 November 2020

Read

Visiongain Publishes Antihypertensive Drugs Market Report 2021-2031

Hypertensive is the most common disease around the world. However, number of people suffering from hypertensive has increased very significantly from last few years. Hypertensive can occur due to consumption of tobacco, too much salt (sodium) and little potassium in your diet, alcohol and to people being overweight or obese.

13 November 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever